Bolus Intravenous Injection of Phosphorothioate Oligonucleotides Causes Hypotension by Acting as 1 -Adrenergic Receptor Antagonists

Author： Iversen P.L.   Cornish K.G.   Iversen L.J.   Mata J.E.   Bylund D.B.  

Publisher： Elsevier

ISSN： 0041-008X

Source： Toxicology and Applied Pharmacology, Vol.160, Iss.3, 1999-11, pp. : 289-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of hydrophobic interactions of antagonists with the beta2-adrenergic receptor

By Novoseletsky V. N.   Pyrkov T. V.   Efremov R. G.  

SAR and QSAR in Environmental Research, Vol. 21, Iss. 1-2, 2010-01 ,pp. : 37-55

Taylor & Francis Ltd

Access to resources Recommend Favorite

Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley rats

By Henry S.P.   Grillone L.R.   Orr J.L.   Bruner R.H.   Kornbrust D.J.  

Toxicology, Vol. 116, Iss. 1, 1997-01 ,pp. : 77-88

Elsevier

Access to resources Recommend Favorite

Urinary elimination of saxitoxin after intravenous injection

By Stafford R.G.   Hines H.B.  

Toxicon, Vol. 33, Iss. 11, 1995-11 ,pp. : 1501-1510

Elsevier

Access to resources Recommend Favorite

Determination of beta-adrenergic receptor blocking pharmaceuticals in united states wastewater effluent

By Huggett D.B.   Khan I.A.   Foran C.M.   Schlenk D.  

Environmental Pollution, Vol. 121, Iss. 2, 2003-02 ,pp. : 199-205

Elsevier

Access to resources Recommend Favorite

Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II–AT1 receptor antagonists based on predictive 3D QSAR models

By Vyas V.K.   Gupta N.   Ghate M.   Patel S.  

SAR and QSAR in Environmental Research, Vol. 25, Iss. 2, 2014-02 ,pp. : 117-146

Taylor & Francis Ltd

Access to resources Recommend Favorite